Skip to main content

Young Alethia

In the past year, 2 open-market sale filings worth $54.6K and no purchases.

Current role at each company

Open-market trades in the past year

Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.

Bought
–
0 filings
Sold
$54.6K
2 filings
Net
−$54.6K
Bought minus sold
Companies
1
With open-market trades

Trades

Every Form 4 that lists Young Alethia as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.

BCYC Bicycle Therapeutics PLC

Chief Financial Officer5 trades

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Jan 6, 2026 (view filing)Jan 2-54 daysYoung AlethiaChief Financial OfficerSSale−7.62K$6.62−$50.5K−8.0%87.1K after3 lots10b5-1
Oct 6, 2025 (view filing)Oct 24 daysYoung AlethiaChief Financial OfficerSSale−482$8.52−$4.10K−1.1%44.7K after2 lots10b5-1
Jul 7, 2025 (view filing)Jul 25 daysYoung AlethiaChief Financial OfficerSSale−204$7.09−$1.45K−0.4%45.2K after
Apr 4, 2025 (view filing)Apr 22 daysYoung AlethiaChief Financial OfficerSSale−215$8.02−$1.72K−0.5%45.4K after
Jan 6, 2025 (view filing)Jan 24 daysYoung AlethiaChief Financial OfficerSSale−1.40K$14.09−$19.7K−3.0%45.6K after

PTCT PTC Therapeutics, Inc.

Director1 trade

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Sep 8, 2023 (view filing)Sep 62 daysYoung AlethiaDirectorSSale−11.7K$39.86−$465.0K−56.3%9.07K after2 lots